• Aucun résultat trouvé

EvoEvo Deliverable 1.4 : Analysis of phenotypic innovation (part 1)

N/A
N/A
Protected

Academic year: 2021

Partager "EvoEvo Deliverable 1.4 : Analysis of phenotypic innovation (part 1)"

Copied!
16
0
0

Texte intégral

Loading

Figure

Figure 1. The eight different hosts used to evaluate TEV phenotypic innovation.  The hosts were chosen  to cover a wide distribution of genetic relatedness with the primary host N
Figure 2.  Relationship between the frequencies of mutant genotypes that are more infectious than the  WT  on  each  host  species
Figure 3.  Relationship between the frequencies of mutant genotypes that had a larger viral load than the  WT  on  each  host  species
Figure 4.  Similarity in transcriptomic profiles between plants of the Ler-0 ecotype infected with each of the evolved viral  lineages
+2

Références

Documents relatifs

In contrast, Rabbit Meadow insects maladaptively preferred senescent over blooming plants (Singer & McBride, 2010).. Here we present data from unpublished censuses to ask whether

Having just completed the family medi- cine certification process (including the Medical Council of Canada Qualifying Examination [MCCQE] Part I and II, and the

burgdorferi species complex revealed a high degree of bacterial diversity within infected chipmunks, bank voles, and wood mice in the forest of Se´nart (France). The observed

The advent of high-throughput sequencing technologies has facilitated analysis of viral population genetics, and these tools are currently used to decipher the genetic structure

3 Worst Value-at-Risk Scenarios for the Multidimensional Problem The above result of Rüschendorf 1982 provides sharpness of the bounds for the n-dimensional problem for

Molecular phylogeography of Chelonus insularis (Hymenoptera: Braconidae) and Campoletis sonorensis (Hymenoptera: Ichneumonidae), two primary neotropical parasitoids of

We also estimated the Bray–Curtis dissimilarities (BCD) as interindividual distances based on mi- crosatellite data (Bray and Curtis 1957) and F ST distances (Weir and Cockerham

Therapeutic drug monitoring (TDM) with trough levels of infliximab (TLI) is considered a promising tool to guide dose adjustments of anti-TNF treatment because of a